The University of Southampton
University of Southampton Institutional Repository

Increase in Matrix Metaloproteinase‐10 is associated with tau, neurodegeneration and reduced brain perfusion in the right temporal lobe

Increase in Matrix Metaloproteinase‐10 is associated with tau, neurodegeneration and reduced brain perfusion in the right temporal lobe
Increase in Matrix Metaloproteinase‐10 is associated with tau, neurodegeneration and reduced brain perfusion in the right temporal lobe
Background: blood brain barrier dysfunction amplifies neuroinflammation, which may drive Alzheimer’s Dementia (AD) pathology. Regional cerebral blood flow (RCBF), measured by HMPAO SPECT, is an established biomarker for AD diagnosis. Matrix Metalloproteinase-10 (MMP-10), an enzyme involved in blood brain barrier function through regulating the breakdown of extracellular matrix, was recently proposed as a biomarker of progression to AD. In this study, we examine the relationship between RCBF and levels of MMP-10 in the cerebrospinal fluid (CSF).

Materials and methods: datasets of 91 participants from a heterogenous clinical cohort, investigated for dementia due to cognitive complaints were analysed. CSF levels of MMP-10 were measured using the OLINK proximity extension array platform. HMPAO SPECT scans were analysed using Statistical Parametric Mapping (SPM). A univariate linear regression model was used in SPM to quantify the impact of MMP-10 changes on brain perfusion.

Results: SPM results showed that higher levels of MMP-10 in CSF are associated with significant reduction in RCBF (family-wise error corrected p
Conclusion: increased levels of MMP-10 in CSF have been associated with blood brain barrier vulnerability and faster cognitive decline in AD. Here we identified a right sided neuroimaging signature in RCBF with increasing levels MMP-10. This may indicate that by the time of symptoms onset the right side is the fastest progressing as it is catching up with the left side. Right sided changes have been previously associated with delusions, disinhibition and irritability in AD and linked with increased carer burden. The significant reduction in RCBF of the right temporal lobe identified in our study, further reinforces a role for MMP-10 as a marker of progression to AD.
1552-5260
Michopoulou, Sofia
888207f0-a8b6-4ecb-ae0c-ad03d2128a2d
Prosser, Angus
de1efee5-67f5-478e-8cfa-12a8e78a68e5
Dickson, John
627f7f54-97e9-4cc1-812c-728c3973265d
Guy, Matt J.
473bbb88-641b-40a5-b22d-221bc048eeb5
Teeling, Jessica
fcde1c8e-e5f8-4747-9f3a-6bdb5cd87d0a
Kipps, Christopher
e43be016-2dc2-45e6-9a02-ab2a0e0208d5
Michopoulou, Sofia
888207f0-a8b6-4ecb-ae0c-ad03d2128a2d
Prosser, Angus
de1efee5-67f5-478e-8cfa-12a8e78a68e5
Dickson, John
627f7f54-97e9-4cc1-812c-728c3973265d
Guy, Matt J.
473bbb88-641b-40a5-b22d-221bc048eeb5
Teeling, Jessica
fcde1c8e-e5f8-4747-9f3a-6bdb5cd87d0a
Kipps, Christopher
e43be016-2dc2-45e6-9a02-ab2a0e0208d5

Michopoulou, Sofia, Prosser, Angus, Dickson, John, Guy, Matt J., Teeling, Jessica and Kipps, Christopher (2023) Increase in Matrix Metaloproteinase‐10 is associated with tau, neurodegeneration and reduced brain perfusion in the right temporal lobe. Alzheimer's & Dementia, 19 (S14), [e072100]. (doi:10.1002/alz.072100).

Record type: Article

Abstract

Background: blood brain barrier dysfunction amplifies neuroinflammation, which may drive Alzheimer’s Dementia (AD) pathology. Regional cerebral blood flow (RCBF), measured by HMPAO SPECT, is an established biomarker for AD diagnosis. Matrix Metalloproteinase-10 (MMP-10), an enzyme involved in blood brain barrier function through regulating the breakdown of extracellular matrix, was recently proposed as a biomarker of progression to AD. In this study, we examine the relationship between RCBF and levels of MMP-10 in the cerebrospinal fluid (CSF).

Materials and methods: datasets of 91 participants from a heterogenous clinical cohort, investigated for dementia due to cognitive complaints were analysed. CSF levels of MMP-10 were measured using the OLINK proximity extension array platform. HMPAO SPECT scans were analysed using Statistical Parametric Mapping (SPM). A univariate linear regression model was used in SPM to quantify the impact of MMP-10 changes on brain perfusion.

Results: SPM results showed that higher levels of MMP-10 in CSF are associated with significant reduction in RCBF (family-wise error corrected p
Conclusion: increased levels of MMP-10 in CSF have been associated with blood brain barrier vulnerability and faster cognitive decline in AD. Here we identified a right sided neuroimaging signature in RCBF with increasing levels MMP-10. This may indicate that by the time of symptoms onset the right side is the fastest progressing as it is catching up with the left side. Right sided changes have been previously associated with delusions, disinhibition and irritability in AD and linked with increased carer burden. The significant reduction in RCBF of the right temporal lobe identified in our study, further reinforces a role for MMP-10 as a marker of progression to AD.

This record has no associated files available for download.

More information

Published date: 1 December 2023

Identifiers

Local EPrints ID: 486252
URI: http://eprints.soton.ac.uk/id/eprint/486252
ISSN: 1552-5260
PURE UUID: c163bfb0-9677-4252-8414-e0a467e315dc
ORCID for Angus Prosser: ORCID iD orcid.org/0000-0003-2705-1222
ORCID for Jessica Teeling: ORCID iD orcid.org/0000-0003-4004-7391
ORCID for Christopher Kipps: ORCID iD orcid.org/0000-0002-5205-9712

Catalogue record

Date deposited: 16 Jan 2024 17:31
Last modified: 27 Apr 2024 02:06

Export record

Altmetrics

Contributors

Author: Sofia Michopoulou
Author: Angus Prosser ORCID iD
Author: John Dickson
Author: Matt J. Guy
Author: Jessica Teeling ORCID iD
Author: Christopher Kipps ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×